CRISPR Therapeutics AG (NASDAQ:CRSP)

83.59
Delayed Data
As of Sep 30
 -1.35 / -1.59%
Today’s Change
32.30
Today|||52-Week Range
105.12
+37.25%
Year-to-Date
Better Buy: CRISPR Therapeutics vs. Editas Medicine
Sep 30 / MotleyFool.com - Paid Partner Content
Beyond Coronavirus: Moderna Teams Up With Vertex on Cystic Fibrosis Therapy
Sep 17 / MotleyFool.com - Paid Partner Content
3 Stocks That Could Double Your Money
Sep 24 / MotleyFool.com - Paid Partner Content
CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow
Sep 11 / Seeking Alpha - Paid Partner Content
CRISPR Therapeutics Gene Therapy CTX001 Gets PRIME Status
Sep 23 / Zacks.com - Paid Partner Content
Editas Medicine up 5% on favorable CRISPR/Cas9 patent ruling
Sep 11 / Seeking Alpha - Paid Partner Content
Crispr: The Frontier Of Gene Editing
Sep 18 / Seeking Alpha - Paid Partner Content